Table 2. Clinicopathologic characteristics of the Chungbuk cohort (n=61): High risk versus low risk MIBCs according to FOXM1 expression.
| Total | % | High Risk | % | Low Risk | % | p-values | |
|---|---|---|---|---|---|---|---|
| Cohort Characteristics | |||||||
| Cohort size | 61 | 10 | (16) | 51 | (84) | ||
| Median age | 66 | 73 | 66 | 0.051 | |||
| Female | 13 | (21) | 4 | (40) | 9 | (18) | 0.198 |
| Male | 48 | (79) | 6 | (60) | 42 | (82) | |
| Progress | 20 | (33) | 3 | (30) | 17 | (33) | 1.000 |
| TNM Staging | |||||||
| pT2 | 31 | (51) | 4 | (40) | 27 | (53) | 0.740 |
| pT3 | 19 | (31) | 4 | (40) | 15 | (29) | |
| pT4 | 11 | (18) | 2 | (20) | 9 | (18) | |
| pN+ | 14 | (23) | 4 | (40) | 10 | (20) | 0.222 |
| cM+ | 6 | (10) | 0 | (0) | 6 | (12) | 0.577 |
| Grading | |||||||
| Low grade | 19 | (31) | 0 | (0) | 19 | (37) | 0.023 |
| High grade | 42 | (69) | 10 | (100) | 32 | (63) | |
| Additional Therapy | |||||||
| Systemic chemotherapy | 26 | (43) | 3 | (30) | 23 | (45) | 0.494 |